Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)

Rowe, Anna (Co-Investigator)
Slade, Daniel (Co-Investigator)
Gates, Simon (Co-Investigator)
Curbishley, Stuart (Researcher)
Homer, Victoria (Principal Investigator)

Cancer Research UK Clinical Trials Unit

Short title	Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Status	Active
Effective start/end date	1/11/21 → 30/04/29

Funding

Medical Research Council

Assessing SPECT/CT for the identification of cartilage lesions in the knee joint: A systematic review
Rix, L., Tushingham, S., Wright, K. & Snow, M. A., Mar 2025, In: Osteoarthritis and Cartilage Open. 7, 1, 7 p., 100577.
Research output: Contribution to journal › Review article › peer-review

Open Access
File